Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Product Development

Accelerating the collection of real-world data about COVID-19

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email

April 24, 2020 11:51 PM UTC
Updated on May 8, 2020 at 12:45 AM UTC

If there are silver linings to the COVID-19 crisis, one is the way groups and individuals who often have adversarial or competitive relationships are joining together to fight a common threat. Another is the acceleration of science and medicine that comes from overcoming barriers that have slowed progress.

The COVID-19 Evidence Accelerator, an initiative of the Reagan-Udall Foundation for the FDA and Friends of Cancer Research, embodies both of these trends. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article